Provider-led access to semaglutide and tirzepatide, with dosing, follow-up, and side-effect support built into your plan.
Provider review within 24 hours
Weekly injectable protocol
Ongoing titration & support
Doctor visit & shipping included
US-made · 503B certified
GLP-1 medications help regulate appetite, fullness, and metabolic signaling. For eligible patients, they can make weight loss feel less like willpower and more like physiology working with you.
Foundry RX protocols are physician-designed, US-compounded, and adjusted over time as your body responds. Not a one-size program. A clinical plan built for you.
Check Eligibility →Average trial results
Average body-weight reduction reported in major semaglutide and tirzepatide trials with diet and lifestyle changes. Individual results vary.
Your provider will recommend the right starting point based on your health profile, goals, and tolerance. Both programs include doctor visit and US shipping.
Same active molecule as Ozempic & Wegovy
A once-weekly injectable that helps regulate appetite, fullness, and blood sugar response. Often a strong starting point for clinically guided weight loss.
Provider review within 24 hours
Same active molecule as Mounjaro & Zepbound
A dual-pathway medication that activates both GLP-1 and GIP receptors. Clinical trials showed higher average trial results for some patients. Your provider determines whether it is appropriate.
Higher average trial results · Provider review within 24 hours
Complete a short medical intake so your provider can understand your history, goals, medications, and eligibility. Takes about ten minutes.
A licensed provider reviews your profile and determines whether GLP-1 treatment is appropriate — and which compound fits your biology.
If prescribed, your medication ships discreetly from a US 503B-certified pharmacy with clear dosing instructions. Arrives in 5–7 days.
Your provider supports dose changes, side effects, and progress over time. Unlimited follow-up is included in your membership.
Doctor of Nursing Practice · Licensed Provider, Foundry RX
Theresa specializes in metabolic health, weight management, and GLP-1 protocols. Every Foundry protocol is reviewed by a licensed US provider — not an algorithm. A real clinical relationship from intake to outcome.
NPI: 1144870056 · Protocol reviewed May 2026 · LegitScript Certified
BMI is a starting point, not the whole story. Your provider reviews your complete health intake and makes an individualized determination.
| BMI Range | GLP-1 Eligibility |
|---|---|
| Below 27 | Generally not indicated |
| 27.0 – 29.9 | Case-by-case with comorbidities |
| 30.0 and above | Likely indicated |
Eligibility is determined at the independent clinical judgment of a licensed US physician after review of your complete health profile. Approval is not guaranteed.
Both programs include your physician consultation, personalized protocol and dose titration, unlimited follow-up, side effect management, and discreet US shipping. Semaglutide starts at $169/month. Tirzepatide starts at $239/month. No hidden fees.
Semaglutide activates the GLP-1 receptor — helping regulate appetite, gastric emptying, and blood sugar. Tirzepatide activates both GLP-1 and GIP receptors, a dual mechanism that clinical trials showed may produce greater average weight reduction for some patients. Your provider will recommend the right starting point.
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. They are prepared by licensed 503B outsourcing facilities — federally registered compounding pharmacies operating under CGMP standards — and prescribed at the independent clinical judgment of a licensed physician.
All Foundry RX compounds are US-made at 503B-certified outsourcing facilities, batch-tested above 99.9% purity before shipping. We do not source from overseas compounders or unverified pharmacies.
Clinical trials of brand-name semaglutide showed average weight loss of approximately 15% of body weight over 68 weeks with lifestyle modifications. Tirzepatide trials showed up to 22% average reduction. Individual results vary based on starting weight, adherence, and titration.
Foundry RX operates in all 50 states through a network of licensed telehealth providers. Medication ships directly from our certified 503B pharmacy to your door.
GLP-1 receptor agonists including compounded semaglutide and tirzepatide may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or MEN 2. Compounded medications are not FDA-approved drugs. All medications prescribed at independent clinical judgment of licensed physicians. Common side effects include nausea, diarrhea, vomiting, and constipation. Membership does not include medication cost. Individual results vary. Not available in all states.
19 pages. Everything the industry won't put in plain language — written for people who want clinical-grade answers without the jargon.
Complete your intake today. If GLP-1 treatment is appropriate, your provider will build a plan around your body, goals, and tolerance.